Skip to content

Needs of ALS Patients With C9orf72 Mutation and Their Caregivers

Investigation Into the Needs of ALS Patients With C9orf72 Mutation and Their Caregivers

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07302321
Acronym
C9survALS
Enrollment
208
Registered
2025-12-24
Start date
2025-10-01
Completion date
2026-06-30
Last updated
2026-02-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Amyotrophic Lateral Sclerosis

Keywords

Amyotrophic Lateral Sclerosis, C9orf72 mutation, Quality of life, Social Care Needs, Caregiver

Brief summary

Individuals with Amyotrophic Lateral Sclerosis (ALS) carrying the C9orf72 HRE mutation (C9Pos) often exhibit different phenotypic traits compared to other patients (C9Neg), presenting a more aggressive form of the disease, with also a higher frequency of comorbidity with frontotemporal dementia (ALS-FTD) and a greater prevalence of family history of ALS and/or other neurodegenerative diseases. Considering these characteristics (comorbidity with FTD and family history of ALS and/or other neurodegenerative pathologies) as factors that have their importance from an assistance point of view, both C9orf72 patients and their caregivers may have particular needs in several respects, and in this sense this investigation is configured. This survey aims to describe the various aspects related to the care and quality of life of C9orf72 ALS patients and their respective caregivers, with the goal of identifying actionable steps to improve the quality of life for both.

Interventions

OTHERSurvey for ALS patients

Survey to describe the various aspects related to the care, needs and quality of life of C9orf72 ALS patients

OTHERSurvey for Caregivers

Survey to describe the various aspects related to the care and time commitment for the assistance given by caregivers to C9orf72 ALS patients

Sponsors

Istituto Auxologico Italiano
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum

Inclusion criteria

ALS Patients: Inclusion Criteria: * Diagnosis of ALS with mutation C9orf72 (C9Pos) * Age 18 years or older * Fluency in Italian language * Ability to understand the nature of the study and to reply to the questions in the online survey * Informed consent signed

Exclusion criteria

* Clinically relevant cognitive dysfunction * Incapacity to reply to at least half of the questions of the online survey * Hospital Anxiety and Depression Scale (HADS) ≥ 11 Caregivers: Inclusion Criteria: * Caregiver of patient with diagnosis of ALS with mutation C9orf72 (C9Pos), who participates in this study * Age 18 years or older * Preserved cognitive functions * Informed consent signed

Design outcomes

Primary

MeasureTime frameDescription
Multidisciplinary careAt enrolmentALS Patients with C9orf72 Mutation: Percentage with Multidisciplinary care
Home careAt enrolmentALS Patients with C9orf72 Mutation: Percentage with Home care
Satisfaction of primary needsAt enrolmentALS Patients with C9orf72 Mutation: Percentage with Satisfaction of primary needs
Satisfaction of economic supportAt enrolmentALS Patients with C9orf72 Mutation: Percentage with Satisfaction of economic support
AgeAt enrolmentCaregivers: Age
Burdensome commitmentAt enrolmentCaregivers: Percentage of caregivers who perceive the assistance as a Burdensome commitment
Psychological supportAt enrolmentCaregivers: Percentage of caregivers who makes use of Psychological support

Countries

Italy

Contacts

CONTACTVincenzo Silani, Prof.
vincenzo.silani@unimi.it+3902619111
CONTACTLuca Grappiolo
luca.grappiolo@auxologico.it+3902619111

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026